Financer l’innovation : conditionner le risque à la rente
In this interview, Théo Bourgeron elucidates the mechanisms employed by investment funds to fund innovation. Leveraging insights from his recent research on finance and the pharmaceutical industry, he emphasizes how, despite some mild resistance, this financing approach is underpinned by a historica...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Article ou chapitre numérique |
| Hizkuntza: | Français |
| Argitaratua: |
2024
|
| Gaiak: | |
| Sarrera elektronikoa: | Accès Université d'Orléans et IFPM Accès Université d'Orléans et IFPM |
| Gaia: | In this interview, Théo Bourgeron elucidates the mechanisms employed by investment funds to fund innovation. Leveraging insights from his recent research on finance and the pharmaceutical industry, he emphasizes how, despite some mild resistance, this financing approach is underpinned by a historically cross-party consensus, thereby constraining the proliferation of critics and alternative methods. |
|---|